Skip to main content

6 results

Biologics and Biosimilars: Expanding Treatment Options for People Living with IBD

December 9, 2022

Whether you currently take medication for inflammatory bowel disease (IBD) or you’re facing a recent diagnosis, you have several treatment options such as biologic therapies which are made with biological material and include biosimilars. Biosimilars are medications that are designed ...

Read more...

Biosimilars role in IBD treatment

August 31, 2021

Dr. Ross Maltz

Have you received a notification from your insurance carrier that coverage of your specialty medication is changing? If so, you aren’t the only one. Many of my patients who are on biologics have been informed by their insurer that they are now required to switch to a biosimilar. I know ...

Read more...

Improving patient & provider education about biosimilars

December 7, 2020

Laura Wingate

When biosimilars first entered the market five years ago, I was excited about new treatment options for patients and for more competition to be created in the market. In the years since, we have seen seven biosimilars approved by the U.S. Food & Drug Administration for IBD indicatio...

Read more...
Sections
Mission (6)
Topics
(X) Biosimilars (6)

Browser not supported

Your Internet Explorer is outdated. For optimal security settings and a better experience on our site, try switching to one of these options:

Google Chrome

Download Chrome

Firefox

Download Firefox

Safari (macOS 10.8+ only)

Download Safari